The Nanomedicine Translation Advisory Board (Nanomed TAB) is a service designed to help the European nanomedicine community NOT to get lost in translation.
It provides a unique, free of charge access to high-level experts who will advise and guide you to accelerate your project to the market.
More than 50 projects have already been supported, receiving one-to-one advice sessions relating to R&D process development, optimisation and scale-up, safety and quality control, clinical investigation, regulatory and reimbursement issues, IPR protection, funding etc.
The most promising projects will be eligible to showcase to clinical trial centres, investors and large companies.
The initiative is by application only, with the next deadline on 24th April 2017: Submit your project online to receive an assessment of the status and prospects of your innovation free of charge.
Selected projects will be invited to join a 2-hour one-to-one session with experts in Gothenburg, Sweden on 31st May, as part of the NanoMed North Annual Meeting 2017.
For further information and to apply, visit the NanoMed TAB website: www.nanomedtab.eu
NANOMEDECINE COMMERCIAL APPLICATION MENTORING